These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 3762199)

  • 1. Comparative study of warfarin versus antiplatelet therapy in patients with a St. Jude Medical valve in the aortic position.
    Hartz RS; LoCicero J; Kucich V; DeBoer A; O'Mara S; Meyers SN; Michaelis LL
    J Thorac Cardiovasc Surg; 1986 Oct; 92(4):684-90. PubMed ID: 3762199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
    Ribeiro PA; Al Zaibag M; Idris M; Al Kasab S; Davies G; Mashat E; Wareham E; Al Fagih M
    J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The St. Jude Medical bileaflet valve prosthesis. A 5 year experience.
    Chaux A; Czer LS; Matloff JM; DeRobertis MA; Stewart ME; Bateman TM; Kass RM; Lee ME; Gray RJ
    J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):706-17. PubMed ID: 6492839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
    Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
    J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 5 1/2 year experience with the St. Jude Medical cardiac valve prosthesis. Early and late results of 737 valve replacements in 671 patients.
    Baudet EM; Oca CC; Roques XF; Laborde MN; Hafez AS; Collot MA; Ghidoni IM
    J Thorac Cardiovasc Surg; 1985 Jul; 90(1):137-44. PubMed ID: 3874324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose anticoagulation after St. Jude Medical prosthesis implantation in patients under 18 years of age.
    Yamak B; Sener E; Kiziltepes U; Gol K; Tarcan O; Mavitas B; Tasdemir O; Bayazit K
    J Heart Valve Dis; 1995 May; 4(3):274-8. PubMed ID: 7655688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term performance of the St. Jude Medical valve: low incidence of thromboembolism and hemorrhagic complications with modest doses of warfarin.
    Kopf GS; Hammond GL; Geha AS; Elefteriades J; Hashim SW
    Circulation; 1987 Sep; 76(3 Pt 2):III132-6. PubMed ID: 3621536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of thrombosis and embolism in children and adolescents with mechanical valve prostheses: warfarin versus antiplatelet agents.
    Khitin LM; Sade RM; Bradley SM; Crawford FA; Widener CE; Stroud MR
    J Heart Valve Dis; 2006 May; 15(3):394-9; discussion 399. PubMed ID: 16784079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aortic valve replacement in patients 50 years old or younger with the St. Jude Medical valve: 14-year experience.
    Tatoulis J; Chaiyaroj S; Smith JA
    J Heart Valve Dis; 1996 Sep; 5(5):491-7. PubMed ID: 8894988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial.
    Colli A; Mestres CA; Castella M; Gherli T
    J Heart Valve Dis; 2007 Nov; 16(6):667-71. PubMed ID: 18095518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late incidence and determinants of stroke after aortic and mitral valve replacement.
    Ruel M; Masters RG; Rubens FD; Bédard PJ; Pipe AL; Goldstein WG; Hendry PJ; Mesana TG
    Ann Thorac Surg; 2004 Jul; 78(1):77-83; discussion 83-4. PubMed ID: 15223407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of the St. Jude Medical heart valve prosthesis. A two-year follow-up of 150 patients.
    Burckhardt D; Hoffmann A; Vogt S; Pfisterer M; Hasse J; Grädel E
    J Thorac Cardiovasc Surg; 1984 Sep; 88(3):432-8. PubMed ID: 6471892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose anticoagulant management of patients with St. Jude Medical mechanical valve prostheses.
    Yamak B; Karagöz HY; Zorlutuna Y; Eralp A; Tasdemir O; Bayazit K
    Thorac Cardiovasc Surg; 1993 Feb; 41(1):38-42. PubMed ID: 8367854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year follow-up after valve replacement with the St. Jude Medical prosthesis in children.
    Harada Y; Imai Y; Kurosawa H; Ishihara K; Kawada M; Fukuchi S
    J Thorac Cardiovasc Surg; 1990 Aug; 100(2):175-80. PubMed ID: 2385115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The artificial St. Jude valve: clinical course and complications recorded in 155 patients].
    Grec V; Goy JJ; Payot M; Sadeghi H; Sigwart U
    Schweiz Med Wochenschr; 1984 Nov; 114(46):1655-60. PubMed ID: 6515367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?
    Sundt TM; Zehr KJ; Dearani JA; Daly RC; Mullany CJ; McGregor CG; Puga FJ; Orszulak TA; Schaff HV
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1024-31. PubMed ID: 15867776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
    Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting performance and thromboembolism after porcine xenograft cardiac valve replacement.
    Geha AS; Hammond GL; Laks H; Stansel HC; Glenn WW
    J Thorac Cardiovasc Surg; 1982 Mar; 83(3):377-84. PubMed ID: 7062749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement.
    Turpie AG; Gent M; Laupacis A; Latour Y; Gunstensen J; Basile F; Klimek M; Hirsh J
    N Engl J Med; 1993 Aug; 329(8):524-9. PubMed ID: 8336751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential for normal long term survival and morbidity rates after valve replacement for aortic stenosis.
    Lund O; Magnussen K; Knudsen M; Pilegaard H; Nielsen TT; Albrechtsen OK
    J Heart Valve Dis; 1996 May; 5(3):258-67. PubMed ID: 8793673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.